Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 264

Similar articles for PubMed (Select 22422574)

1.

Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital.

Yu HT, Wang Q, Yang N, Li HM, Liang JQ, Liu CH.

J Med Microbiol. 2012 Jul;61(Pt 7):960-7. doi: 10.1099/jmm.0.042655-0. Epub 2012 Mar 15.

PMID:
22422574
2.

Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.

Minato Y, Thiede JM, Kordus SL, McKlveen EJ, Turman BJ, Baughn AD.

Antimicrob Agents Chemother. 2015 Jun 1. pii: AAC.00647-15. [Epub ahead of print]

PMID:
26033719
3.

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.

Kempker RR, Kipiani M, Mirtskhulava V, Tukvadze N, Magee MJ, Blumberg HM.

Emerg Infect Dis. 2015 Jun;21(6):992-1001. doi: 10.3201/eid2106.141873.

4.

Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010.

Smith SE, Ershova J, Vlasova N, Nikishova E, Tarasova I, Eliseev P, Maryandyshev AO, Shemyakin IG, Kurbatova E, Cegielski JP.

Emerg Infect Dis. 2015 Jun;21(6):1002-11. doi: 10.3201/eid2106.141907.

5.

Tackling challenges of TB/MDRTB in China: concerted actions are imperative.

Tang S.

Infect Dis Poverty. 2015 Apr 16;4:19. doi: 10.1186/s40249-015-0050-4. eCollection 2015.

6.

Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.

Chakraborty S, Rhee KY.

Cold Spring Harb Perspect Med. 2015 Apr 15. pii: a021147. doi: 10.1101/cshperspect.a021147. [Epub ahead of print]

PMID:
25877396
7.

Predictors of drug resistance in tuberculosis patients in the Eastern Province, Saudi Arabia.

El Mahalli AA, Al-Qahtani MF.

J Egypt Public Health Assoc. 2015 Mar;90(1):24-8. doi: 10.1097/01.EPX.0000461677.83722.78.

PMID:
25853542
8.

Molecular Characteristics and Drug Susceptibility of Mycobacterium tuberculosis Isolates from Patients Co-infected with Human Immunodeficiency Virus in Beijing, China.

Liu J, Wang HZ, Lian LL, Yu YH, Zhao XQ, Guo CP, Liu HC, Liu SM, Zhao H, Zeng ZY, Zhao XY, Wan KL.

Biomed Environ Sci. 2015 Mar;28(3):222-6. doi: 10.3967/bes2015.030.

9.

Fructose restores susceptibility of multidrug-resistant Edwardsiella tarda to kanamycin.

Su YB, Peng B, Han Y, Li H, Peng XX.

J Proteome Res. 2015 Mar 6;14(3):1612-20. doi: 10.1021/pr501285f. Epub 2015 Feb 20.

PMID:
25675328
10.

Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country.

Lee YS, Kang MR, Jung H, Choi SB, Jo KW, Shim TS.

J Infect Chemother. 2015 May;21(5):346-51. doi: 10.1016/j.jiac.2014.12.009. Epub 2015 Jan 9.

PMID:
25634305
11.

Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.

Li N, Liao X, Chen L, Wang J, Liu M, Zhang H.

Microb Drug Resist. 2015 Jun;21(3):292-6. doi: 10.1089/mdr.2014.0094. Epub 2015 Jan 19.

PMID:
25599413
12.

Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey.

Kamal SM, Hossain A, Sultana S, Begum V, Haque N, Ahmed J, Rahman TM, Hyder KA, Hossain S, Rahman M, Ahsan CR, Aung KJ, Islam A, Hasan R, Van Deun A.

Int J Tuberc Lung Dis. 2015 Feb;19(2):151-6. doi: 10.5588/ijtld.14.0200. Erratum in: Int J Tuberc Lung Dis. 2015 May;19(5):622. Chowdhury, R A [corrected to Ahsan, Chowdhury R].

PMID:
25574912
13.

Comparing risk factors for primary multidrug-resistant tuberculosis and primary drug-susceptible tuberculosis in Jiangsu province, China: a matched-pairs case-control study.

Li XX, Lu W, Zu RQ, Zhu LM, Yang HT, Chen C, Shen T, Zeng G, Jiang SW, Zhang H, Wang LX.

Am J Trop Med Hyg. 2015 Feb;92(2):280-5. doi: 10.4269/ajtmh.13-0717. Epub 2014 Dec 22.

14.

Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.

Zhang X, Liu L, Zhang Y, Dai G, Huang H, Jin Q.

Antimicrob Agents Chemother. 2015 Feb;59(2):1320-4. doi: 10.1128/AAC.03695-14. Epub 2014 Nov 24.

PMID:
25421465
15.

Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru.

Shah L, Choi HW, Berrang-Ford L, Henostroza G, Krapp F, Zamudio C, Heymann SJ, Kaufman JS, Ciampi A, Seas C, Gotuzzo E, Brewer TF.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1307-14. doi: 10.5588/ijtld.14.0011.

PMID:
25299862
16.
17.

Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics.

Xu B, Zhao Q, Hu Y, Shi Y, Wang W, Diwan VK.

Glob Health Action. 2014 Aug 18;7:24593. doi: 10.3402/gha.v7.24593. eCollection 2014.

18.

Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors.

Rifat M, Milton AH, Hall J, Oldmeadow C, Islam MA, Husain A, Akhanda MW, Siddiquea BN.

PLoS One. 2014 Aug 19;9(8):e105214. doi: 10.1371/journal.pone.0105214. eCollection 2014.

19.

Social and clinical predictors of drug-resistant tuberculosis in a public hospital, Monterrey, Mexico.

Young BN, Burgos M, Handal AJ, Baker J, Rendón A, Rosas-Taraco A, Long J, Hunley K.

Ann Epidemiol. 2014 Oct;24(10):771-5. doi: 10.1016/j.annepidem.2014.07.001. Epub 2014 Jul 10.

PMID:
25107834
20.

Association of MDR-TB isolates with clinical characteristics of patients from Northern region of India.

Gupta A, Nagaraja MR, Kumari P, Singh G, Raman R, Singh SK, Anupurb S.

Indian J Med Microbiol. 2014 Jul-Sep;32(3):270-6. doi: 10.4103/0255-0857.136561.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk